CA Stock MarketDetailed Quotes

Helix BioPharma Corp (HBP)

Watchlist
  • 1.710
  • 0.0000.00%
15min DelayTrading Mar 25 16:00 ET
130.61MMarket Cap-28.50P/E (TTM)

Helix BioPharma Corp (HBP) Revenue Breakdown Overview

By Business/Source

No Data

By Product

No Data

By Industry

No Data

By Country/Region

Currency:CAD
2013/FY
Stock NameRevenueRatio
DomesticSegments1.72M91.92%
Canada1.72M91.92%
United States151K8.08%
ForeignSegments151K8.08%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospects of a ceasefire negotiation between the US and Iran have been dominating market sentiment. On March 26, Eastern Time, Show More